PURPOSE Neoadjuvant chemotherapy (NAC) has potential advantages over standard
postoperative chemotherapy for locally advanced colon cancer but requires formal …

Surgery with or without adjuvant chemotherapy is the standard treatment for early-stage
colon cancer. However, evidence has recently emerged for neoadjuvant chemotherapy, with …

BACKGROUND. CT is the standard-of-care test for preoperative locoregional staging of
colon cancer (CC) but has limited diagnostic performance. More accurate preoperative …

Objective To determine the accuracy of computed tomography (CT)-based staging in
selecting high-risk colon cancer patients who would benefit from neoadjuvant chemotherapy …

Background Tumour deposits are suggested to impact prognosis in colon cancer negatively.
This study assessed the impact of tumour deposits on oncological outcomes. Methods Data …

Background Controversy persists about neoadjuvant chemotherapy (NAC) within the field of
locally advanced colon cancer (LACC). The purpose of this study was to assess the existing …

Objective: This study aimed to identify risk criteria available before the point of treatment
initiation that can be used to stratify the risk of obstruction in patients undergoing …

Introduction In an era of exploring patient-tailored treatment options for colon cancer,
preoperative staging is increasingly important. This study aimed to evaluate completeness …

Neoadjuvant chemotherapy (NAC) has long been considered technically difficult in locally
advanced colon cancer (LACC). However, the introduction of oxaliplatin-based regimens led …

Colon cancer is a leading cause of cancer-related mortality worldwide, with an estimated
106,180 new cases in 2022. 1 Locally advanced colon cancer (LACC) is particularly …